Literature DB >> 12114044

Adiponectin and development of type 2 diabetes in the Pima Indian population.

Robert S Lindsay1, Tohru Funahashi, Robert L Hanson, Yuji Matsuzawa, Sachiyo Tanaka, P Antonio Tataranni, William C Knowler, Jonathan Krakoff.   

Abstract

Adiponectin is a collagen-like circulating protein secreted by adipocytes that is proposed to mediate obesity-related resistance to insulin. In a case-control series, we assessed the role of adiponectin in later development of type 2 diabetes in 70 patients who later developed type 2 diabetes and 70 controls, matched for body-mass index, age, and sex. Cases and controls were taken from the longitudinal study of health in the Pima Indian population. At baseline, the concentration of adiponectin was lower in cases than in controls (p=0.01) and individuals with high concentrations of this protein were less likely to develop type 2 diabetes than those with low concentrations (incidence rate ratio 0.63 [95% CI 0.43-0.92]; p=0.02).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114044     DOI: 10.1016/S0140-6736(02)09335-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  233 in total

Review 1.  Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  L Y Han; Q H Wu; M L Jiao; Y H Hao; L B Liang; L J Gao; D G Legge; H Quan; M M Zhao; N Ning; Z Kang; H Sun
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

2.  Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the Manchester children's growth and vascular health study.

Authors:  Narinder Bansal; Simon G Anderson; Avni Vyas; Isla Gemmell; Valentine Charlton-Menys; John Oldroyd; Philip Pemberton; Paul N Durrington; Peter E Clayton; J Kennedy Cruickshank
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

Review 3.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 4.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 5.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

6.  Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Authors:  Kamal H Sharma; Komal H Shah; Iva Patel; Alap K Patel; Subhash Chaudhari
Journal:  Indian Heart J       Date:  2015-08-06

7.  Review: Metabolic Syndrome in Black South African Women.

Authors:  Philippe Jean-Luc Gradidge; Nigel J Crowther
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

8.  Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

Authors:  Katarzyna Dunajska; Andrzej Milewicz; Diana Jedrzejuk; Jadwiga Szymczak; Wiktor Kuliczkowski; Piotr Salomon; Dariusz Bialy; Karol Poczatek; Przemysław Nowicki
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

9.  Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.

Authors:  J Frystyk; L Tarnow; T Krarup Hansen; H-H Parving; A Flyvbjerg
Journal:  Diabetologia       Date:  2005-08-03       Impact factor: 10.122

10.  The association of serum adiponectin levels with histopathological variables in gastric cancer patients.

Authors:  Mesut Seker; Ahmet Bilici; Berkant Sonmez; Bala Basak Oven Ustaalioğlu; Mahmut Gumus; Hulya Gozu; Mehmet Sargin; Asuman Orcun; Cem Gezen; Mehmet Eser; Nejdet Bildik; Taflan Salepci
Journal:  Med Oncol       Date:  2009-12-16       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.